Posts tagged British Unicorn
BenevolentAI raises $115 million to extend its leading global position in the field of AI enabled drug development

BenevolentAI raises $115 million, now valued at $2 billion. Funds raised to significantly scale BenevolentAI drug development activities, broaden the disease areas on which it focuses, and extend its AI platform capabilities

Read More